###begin article-title 0
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 25 34 25 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
Regulation of the Pax6 : Pax6(5a) mRNA ratio in the developing mammalian brain
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 542 547 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 551 560 551 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 609 616 609 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Early in mammalian brain development cell proliferation generates a population of progenitor cells whose subsequent divisions produce increasing numbers of postmitotic neurons. Pax6 affects both processes and it has been suggested that this changing role is due at least in part to changes in the relative concentrations of its two main isoforms, (i) Pax6 and (ii) Pax6(5a), created by insertion of a 42 bp exon (exon 5a) into one of the two DNA-binding domains. Crucially, however, no previous study has determined whether the ratio between Pax6 and Pax6(5a) transcripts alters during mammalian neurogenesis in vivo.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 146 152 <span type="species:ncbi:10090">murine</span>
Using RNase protection assays, we show that Pax6 transcripts are 6-10 times more prevalent than Pax6(5a) transcripts early in neurogenesis in the murine telencephalon, diencephalon and hindbrain and that the ratio later falls significantly to about 3:1 in these regions.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 103 112 103 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
These changes in vivo are similar in magnitude to those shown previously to alter target gene activity in vitro and might, therefore, allow the single mammalian Pax6 gene to carry out different functions at different times in mammalian brain development.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 399 404 399 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 610 619 610 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 723 724 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 838 839 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
Pax6 is expressed in the developing eye and brain, where it affects both progenitor cell production and neuronal differentiation [1-5]. The Pax6 protein contains two DNA binding domains, a paired domain (PD) and a paired-type homeodomain (HD) (Fig. 1A). The PD consists of two separate helix-turn-helix motifs, termed PAI and RED, which act on different target sequences [6]. The best characterised Pax6 alternative splicing event, involving the insertion of a 42 bp exon (exon 5a) into the PAI subdomain of the PD, results in two major Pax6 isoforms [Pax6 and Pax6(5a)] with different DNA-binding properties. In vitro studies have shown that the PAI subdomain of Pax6 binds preferentially to a consensus sequence (P6CON) [7] but that PAI subdomain disruption in Pax6(5a) allows the RED subdomain to bind an alternative sequence (5aCON) [6].
###end p 9
###begin p 10
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 22 30 22 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a)</italic>
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 113 122 113 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 204 209 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 221 230 221 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 295 300 295 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 485 491 485 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 792 797 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 814 823 813 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
Detection of Pax6 and Pax6(5a). (A) Riboprobe design. The ssRNA antisense riboprobe used to detect both Pax6 and Pax6(5a) spans the Pax6 mRNA from exon 3 to exon 5a. Two protected fragments are produced, Pax6 (218nt) and Pax6(5a) (247nt). The PD- and HD-coding regions are represented above the Pax6 mRNA sequence, which is shown to scale. Grey and black bars are exons. Broken line shows part of the riboprobe derived from the vector. (B) Example of an RNase protection assay showing GAPDH and Pax6 signal detected in total RNA from E12.5 eye (E), diencephalon (D) and telencephalon (T). 1 mug total RNA was used in each sample. Central lane is a DNA ladder, which allows approximate sizing of bands (fragment sizes are indicated above bands). (C) Quantification of RNase protection assays. Pax6 (lower band) and Pax6(5a) (upper band) in the telencephalon, diencephalon and eye at E12.5 and E18.5. Gel images and densitometric traces of bands are shown. Level of background estimated using the rolling disk method (Quantity One software, Biorad) is indicated on each trace.
###end p 10
###begin p 11
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 337 344 337 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 484 488 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 520 525 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 529 538 529 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 638 639 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 994 1002 994 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Pax6 affects early progenitor cell proliferation and later neuronal differentiation in the developing brain [4,5]. This changing role might be due at least in part to a shift in the relative concentrations of Pax6 and Pax6(5a) during development but there has been no previous report of such alterations during neurogenesis in the brain in vivo. We anticipated that even relatively small changes in the Pax6 : Pax6(5a) ratio might be important since stronger effects on gene activity via P6CON and 5aCON are observed if Pax6 and Pax6(5a) are introduced into cultured cell lines at ratios of 1:1 or 8:1 than at ratios of 2:1, 4:1 or 16:1 [8]. We selected a direct method for quantification of the ratio (RNase protection assays) and carried out multiple assays so as to obtain statistically analysable data on key Pax6-expressing brain tissues at a range of ages throughout neurogenesis. We found changes in the ratio similar in magnitude to those shown previously to alter target gene activity in vitro.
###end p 11
###begin title 12
Results and Discussion
###end title 12
###begin p 13
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 160 169 160 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 608 609 608 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 840 845 840 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 847 856 847 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 996 997 996 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1012 1017 1012 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 1019 1028 1019 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 1095 1096 1095 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1448 1453 1448 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 1457 1466 1457 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
RNase protection assays were carried out on tissues dissected from wild type mouse embryos aged E12.5-E18.5 and quantified by densitometry (Fig. 1). The Pax6 : Pax6(5a) ratio varied throughout neurogenesis in the telencephalon, diencephalon and hindbrain, following a similar pattern in each (Table 1). In the telencephalon, the ratio was about 6:1 early in neurogenesis, at E12.5, but was significantly lower (about 2:1) at each subsequent age (p < 0.05-p < 0.01; Table 1). In the diencephalon and hindbrain, ratios were about 8:1 and 10:1 at E12.5 but were lower (about 2:1 to 4:1) from E14.5-E18.5 (Table 1); these decreases were statistically significant when data from all three age groups were combined (p < 0.05 for both tissues). Combining results from the telencephalon, diencephalon and hindbrain showed a significant fall in the Pax6 : Pax6(5a) ratio between E12.5 and E14.5, from approximately 8:1 to 3:1 (p < 0.05), with a further slight decrease at E16.5 and E18.5 (p < 0.01; Table 1). Data on the Pax6 : Pax6(5a) ratio in the eye at E12.5-E18.5 did not show the same trend (Table 1). Ratios varied from about 10:1 at E14.5 to about 4:1 at E18.5 but none of the differences were statistically significant. Although we did not detect significant changes in the eye, it is possible that non-synchronised changes in the ratio do occur within its component Pax6-expressing neural and non-neural tissues (cornea, lens and retina). Neither Pax6 nor Pax6(5a) was detected in samples from the feet.
###end p 13
###begin p 14
###xml 5 9 5 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 11 20 11 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 293 294 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Mean Pax6: Pax6(5a) ratios +/- SEMs. "Combined" data are from telencephalon, diencephalon and hindbrain considered together at each age. For each tissue and for combined brain tissues, significant differences between values at E12.5 and values at subsequent ages are shown (unpaired Student's t-tests; * = p < 0.05, ** = p < 0.01). Numbers of individual assays are indicated in brackets.
###end p 14
###begin p 15
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 149 157 149 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a)</italic>
###xml 175 198 175 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 200 208 200 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ey/ toy </italic>
###xml 212 220 212 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eyg/ toe</italic>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 610 611 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 653 658 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 660 669 660 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 175 198 <span type="species:ncbi:7227">Drosophila melanogaster</span>
There is evidence that Pax6 and Pax6(5a) have different functions in vivo in both vertebrates [9-11] and invertebrates [12,13]. Studies of Pax6- and Pax6(5a)-related genes in Drosophila melanogaster, ey/ toy and eyg/ toe, have shown that they promote, respectively, differentiation and proliferation of eye precursor cells [12,13]. Overexpression of Pax6 and Pax6(5a) can alter the expression of different sets of genes in mammals [10,11]. Mammalian brain cells reduce their proliferation in response to overexpression of Pax6 or Pax6(5a) and increase their neurogenesis in response to overexpression of Pax6 [9]. It is possible that a reduction in the Pax6 : Pax6(5a) mRNA ratio from E14.5 is involved in programming progenitor cells to initiate processes that occur later in embryogenesis. Such processes are potentially numerous; they might, for example, include the transition from predominantly neurogenesis to the major phase of gliogenesis or the development of specific sets of later-generated neurones such as the superficial layers of the cerebral cortex.
###end p 15
###begin title 16
Conclusion
###end title 16
###begin p 17
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 28 37 28 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 212 221 212 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
We conclude that the Pax6 : Pax6(5a) ratio falls in the telencephalon, diencephalon and hindbrain during neurogenesis and, moreover, the magnitude of the change is in the range that alters target gene expression in vitro [8]. This finding allows the possibility that changes in the relative expression levels of isoforms of a single Pax6 gene might result in changes in the functions of this gene in mammalian brain development.
###end p 17
###begin title 18
Methods
###end title 18
###begin p 19
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 682 687 682 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 691 700 691 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6(5a) </italic>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 850 855 850 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 861 866 861 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 929 934 929 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 984 989 984 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 1246 1255 1246 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1315 1317 1310 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 844 849 <span type="species:ncbi:10090">mouse</span>
###xml 1118 1124 <span type="species:ncbi:10090">murine</span>
For each RNase protection assay, wild-type mice (CD-1) were time-mated [the day of conception was designated embryonic day 0.5 (E0.5)] and killed on E12.5, E14.5, E16.5 or E18.5. The telencephalon, diencephalon, hindbrain, eyes and feet (used as a Pax6 non-expressing control tissue) were dissected from each embryo. Tissues from multiple embryos were combined so as to obtain sufficient material for each assay. Total RNA was isolated from tissue snap-frozen in liquid nitrogen, its integrity was checked by agarose gel electrophoresis and its concentration was measured using a fluorimeter. The riboprobe was designed to span the Pax6 mRNA from exon 3 to exon 5a so as to protect Pax6 and Pax6(5a) mRNAs (Fig. 1A). Oligonucleotides 5'-AAG TGG ACG TAT ATC CCA GTT CTC-3' and 5'-AGC ACC TGG ACT TTT GCA TC-3' were used to amplify sequence from mouse Pax6 cDNA. Pax6 cDNA was cloned into pCR-BluntII-TOPO and sequenced across the Pax6 insert in both directions to identify clones with Pax6 sequence in the appropriate orientation to generate antisense probe. The plasmid pTRI-GAPDH (Ambion) was used for synthesis of a murine glyceraldehyde-3-phosphate dehydrogenase (GAPDH) riboprobe. Riboprobe synthesis was carried out using the Maxiscript SP6 in vitro transcription kit (Ambion) in the presence of 40 muCi alpha-32P-UTP 800 Ci/mmol (Amersham). Riboprobes were purified using a MicroSpin G25 column (Amersham Biosciences).
###end p 19
###begin p 20
###xml 308 314 306 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 335 337 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 528 534 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 871 873 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 881 883 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1000 1001 998 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
RNase protection assays were performed on 1 mug total RNA from E12.5 and E14.5 embryonic tissues, or 4 mug total RNA from E16.5 and E18.5 embryonic tissues, using the Hyb Speed kit (Ambion). The quality the undigested full-length riboprobe was examined and that of all total RNA samples was assessed using a GAPDH riboprobe (e.g. Fig. 1B). Products were resolved on 6% polyacrylamide, 8 M urea gels that were then fixed (15% methanol, 5% acetic acid for 30 minutes), dried and exposed to film with an intensifying screen. Where GAPDH signal was weak, this was a sign that protein or DNA contamination had led to inaccurate RNA quantification, and these samples were excluded from subsequent analyses. Gel bands were quantitated using a GS-710 densitometer and the Quantity One software package (BioRad: background subtraction was performed using the rolling disk method [14]; Fig. 1C). Each assay was repeated several times (n values for the number of assays for each tissue at each age are in Table 1).
###end p 20
###begin title 21
Authors' contributions
###end title 21
###begin p 22
JP carried out all the RNase protections assays, analysed the results and wrote a first draft of the manuscript. JP, JM, IS and DP all helped conceive and design the study and all worked on and approved the final manuscript.
###end p 22
###begin title 23
Acknowledgements
###end title 23
###begin p 24
Many thanks to Karen Chapman for advice on RNase protection, and to Tom Pratt and Jane Quinn for help with dissections. This work was funded by the Wellcome Trust.
###end p 24
###begin article-title 25
###xml 9 15 <span type="species:ncbi:10090">murine</span>
Pax-6, a murine paired box gene, is expressed in the developing CNS
###end article-title 25
###begin article-title 26
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse small eye results from mutations in a paired-like homeobox-containing gene
###end article-title 26
###begin article-title 27
Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region
###end article-title 27
###begin article-title 28
Glial cells generate neurons: the role of the transcription factor Pax6
###end article-title 28
###begin article-title 29
Pax6 is required to regulate the cell cycle and the rate of progression from symmetrical to asymmetrical division in mammalian cortical progenitors
###end article-title 29
###begin article-title 30
Two independent and interactive DNA-binding subdomains of the Pax6 paired domain are regulated by alternative splicing
###end article-title 30
###begin article-title 31
Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes
###end article-title 31
###begin article-title 32
Functional interactions between alternatively spliced forms of Pax6 in crystallin gene regulation and in haploinsufficiency
###end article-title 32
###begin article-title 33
Molecular dissection of Pax6 function: the specific roles of the paired domain and homeodomain in brain development
###end article-title 33
###begin article-title 34
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
A comparative cDNA microarray analysis reveals a spectrum of genes regulated by Pax6 in mouse lens
###end article-title 34
###begin article-title 35
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Identification of genes downstream of Pax6 in the mouse lens using cDNA microarrays
###end article-title 35
###begin article-title 36
###xml 91 114 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Growth and specification of the eye are controlled independently by Eyegone and Eyeless in Drosophila melanogaster
###end article-title 36
###begin article-title 37
Growth and specification: fly Pax6 homologs eyegone and eyeless have distinct functions
###end article-title 37
###begin article-title 38
Tyrosine phosphorylation of platelet derived growth factor beta receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris
###end article-title 38

